Physician

Wael S. Abo-Auda, M.D.

According to 2025 Medicare claims, Wael Abo-Auda, M.D. (NPI: 1891782512) practices cardiology in the Sherman-Denison, TX market, with the plurality of this provider's patient population coming from Grayson, TX. This provider's primary affiliated billing organization is ABO-AUDA ASSOCIATES PLLC (NPI: 1083975429) and primary practice location at 75071-7824. Abo-Auda is affiliated with the Baylor Scott & White Quality Alliance (ACO ID: A2542) and CHSPSC ACO 8, LLC (ACO ID: A3715), participating under the MSSP model.

Abo-Auda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,935 traditional Medicare patients, billed 18,712 HCPCS/CPT codes, and received $948,436 in Medicare payments. The top billing code was 93880 (Ultrasound of both sides of head and neck blood flow). Part D data shows 8,597 prescription claims across 959 beneficiaries totaling $1,376,904 in drug costs, led by Eliquis (Apixaban). DME data shows 12 claims. Open Payments data shows 79 records totaling $228,791. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $388,862 to $948,436. Similarly, Part D prescription costs have moved sharply higher in recent years, from $84,607 to $1,376,904. In contrast, DME billing represents a smaller volume and declined steadily, from $122,986 to $5,672.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,080	7,268	$388,862
2016	2,441	9,083	$445,087
2017	2,300	8,724	$485,212
2018	2,154	8,262	$546,529
2019	2,336	8,701	$566,524
2020	1,609	7,458	$570,860
2021	1,648	7,219	$553,502
2022	1,365	7,317	$556,619
2023	1,854	18,762	$940,649
2024	1,935	18,712	$948,436

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	207	1,999	$84,607
2016	212	2,352	$111,603
2017	306	3,021	$221,200
2018	373	3,640	$290,683
2019	429	3,901	$482,424
2020	499	4,680	$718,344
2021	603	5,548	$923,707
2022	710	7,055	$1,101,043
2023	870	8,058	$1,358,018
2024	959	8,597	$1,376,904

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	17	61	$121,623
2016	25	58	$117,017
2017	23	52	$109,060
2018	14	32	$66,663
2019	21	59	$124,043
2020	14	35	$74,320
2021	13	52	$105,370
2022	N/R	21	$49,234
2023	N/R	N/R	N/R
2024	N/R	12	$2,096

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93880	Ultrasound of both sides of head and neck blood flow	401	435	$130
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	870	953	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	707	1,905	$91
75574	Ct scan of blood vessels and grafts of heart with contrast	410	415	$83
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	825	1,366	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	569	26,980	$518,363
Repatha Sureclick	Evolocumab	195	7,542	$145,836
Brilinta	Ticagrelor	171	8,940	$130,165
Jardiance	Empagliflozin	133	5,740	$109,256
Entresto	Sacubitril/Valsartan	109	5,200	$85,945

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0471	Respiratory assist device, bi-level pressure capability, with back-up rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	N/R	12	$2,096

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	55	$1,545	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	24	$227,245	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Wael S. Abo-Auda, M.D.?

Tedicare shows public-source Medicare data for Wael S. Abo-Auda, M.D. (NPI 1891782512), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wael S. Abo-Auda, M.D. have ACO affiliation data?

Wael S. Abo-Auda, M.D. is shown with ACO affiliation data for Baylor Scott & White Quality Alliance (MSSP, ACO ID A2542) and CHSPSC ACO 8, LLC (MSSP, ACO ID A3715).

What billing organization is linked to Wael S. Abo-Auda, M.D.?

Wael S. Abo-Auda, M.D. is linked to ABO-AUDA ASSOCIATES PLLC (billing NPI 1083975429) in the available physician profile data.

Does Wael S. Abo-Auda, M.D. have Open Payments data?

Wael S. Abo-Auda, M.D. has 79 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.